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Abstract
Background: Mechanisms underlying pain in chronic pancreatitis (CP) are incompletely understood. Our previous
data showed that astrocytes were actively involved. However, it was unclear how astrocytic activation was induced
in CP conditions. In the present study, we hypothesized that toll-like receptors (TLRs) were involved in astrocytic
activation and pain behavior in CP-induced pain.
Results: To test our hypothesis, we first investigated the changes of TLR2-4 in the rat CP model induced by
intrapancreatic infusion of trinitrobenzene sulfonic acid (TNBS). Western blot showed that after TNBS infusion, TLR3,
but not TLR2 or TLR4, was increased gradually and maintained at a very high level for up to 5 w, which correlated
with the changing course of mechanical allodynia. Double immunostaining suggested that TLR3 was highly
expressed on astrocytes. Infusion with TLR3 antisense oligodeoxynucleotide (ASO) dose-dependently attenuated
CP-induced allodynia. CP-induced astrocytic activation in the spinal cord was also significantly suppressed by TLR3
ASO. Furthermore, real-time PCR showed that IL-1b, TNF-a, IL-6 and monocyte chemotactic protein-1 (MCP-1) were
significantly increased in spinal cord of pancreatic rats. In addition, TLR3 ASO significantly attenuated CP-induced
up-regulation of IL-1b and MCP-1.
Conclusions: These results suggest a probable “TLR3-astrocytes-IL-1b/MCP-1” pathway as a positive feedback loop
in the spinal dorsal horn in CP conditions. TLR3-mediated neuroimmune interactions could be new targets for
treating persistent pain in CP patients.
Background
Chronic pancreatitis (CP) is a severe inflammatory and
painful disease of the exocrine pancreas. Constant,
recurrent, and serious abdominal pain is one of the
most common symptoms in CP, present in 80-90% of
the patients [1]. However, the pain mechanisms in CP
are incompletely understood and probably are multifac-
torial, including pancreatic and extrapancreatic causes
[2]. Experimental human pain studies show that pain
processing in the central nervous system (CNS) is
abnormal in CP-related neuropathic pain disorders [3,4].
A recent study showed that in the patients of CP and
pancreatic cancer, pancreatic neuropathy could bring
“neural remodeling” and alter pancreatic innervation [5].
These results highly suggest that neuroplastic changes
in the CNS are probably important contributors to the
CP-induced chronic pain. And it has been reported that
pain in CP shares many characteristics of neuropathic
pain [6-8].
Neuron-immune interactions and neuron-glial cross-
talk in the spinal dorsal horn play a pivotal role in neu-
roplastic changes and neuropathic pain [9,10]. The
involvement of neuroimmune interactions in CP-
induced pain has also been reported [2]. Our recent
study showed that astrocytes were activated in the thor-
acic spinal cord in a rat model of CP induced by intra-
pancreatic infusion of trinitrobenzene sulfonic acid
(TNBS), and inhibiting astrocytic activation could
attenuate pain of CP [11]. We thus estimated that, in
CP conditions, astrocytes might be activated through
some receptors, and then produced signaling molecules
that could further enhance neuronal activity, contribut-
ing to pain facilitation [12]. However, it is still unclear
which receptor(s) mediated astrocytic activation in CP
conditions.
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neuron-immune interactions and neuron-glial crosstalk
in chronic pain conditions [13-15]. TLR2-4 have been
clarified to be major mediators in neuropathic pain
[14,16,17]. In general, in response to stimulation by
endogenous and exogenous signals, TLRs could induce
glial activation in which multiple TLRs could trigger
and tailor innate immune responses of glia by altering
production of pain-associated pro-inflammatory cyto-
kines/chemokines [15]. However, there is still no report
on the contribution of TLRs in CP related pain. Inter-
estingly, TLRs have been implicated in the process of
pancreatitis [18]. A recent study showed that intraperi-
toneal injection of TLR3 activator could successfully
induce CP-like pathological changes [19].
In the present study, we hypothesized that TLRs
(TLR2-4) were involved in astrocytic activation and pain
behavior in the process of CP-induced pain. To test our
hypothesis, we first investigated the expression changes
of TLR2-4 following TNBS-induced CP. We found that
TLR3, but not TLR2 or 4, was increased in the thoracic
spinal dorsal horn in the process of CP. Then we
detected the cellular localization of TLR3 with double
immunostaining and observed that TLR3 was highly
expressed on spinal astrocytes. We further used a kind
of TLR3 antisense oligodeoxynucleotide (ASO) to
decrease the expression of TLR3 and observed the beha-
vioral and biochemical changes in the spinal cord.
Results
TNBS infusion induced CP and mechanical allodynia
In the naïve and sham rats, the pancreas presented a nor-
mal appearance. While in 5 w after TNBS infusion, the
pancreas showed significant acinar atrophy, inflammatory
infiltration, and periductular and intralobular fibrosis,
stromal proliferation (Figure 1). CP-induced persistent
mechanical allodynia is characterized by increase of
abdomen response frequencies (RFs) [4,7]. We observed
that rats with CP showed persistent mechanical hyper-
sensitivity in the abdomen. The mechanical allodynia was
evident 1 w (RFs = 49.6 ± 7.5% for TNBS group, P < 0.05,
vs naive group; Figure 2A) after TNBS infusion and per-
sistent up to 5 w (RFs = 70.2 ± 5.9% for TNBS group, P <
0.05, vs naive group). There was no significant difference
between sham and naive group at any time points. Then,
we examined the effects of different stimulations on RFs
of rats with von-Frey filaments of various strengths from
2.29 to 120 mN on 5 w post CP induction. We observed
that at 5 w after TNBS infusion, RFs of rats were signifi-
cantly higher at all filaments tested compared to either
sham or to naive rats (P < 0.05, Figure 2B). Thus we con-
firmed that intrapancreatic infusion of TNBS produced
CP and increased the sensitivity to mechanical probes in
the abdomen.
CP significantly up-regulated TLR3 expression in the
thoracic spinal dorsal horn
We then sacrificed the rats at different time points and
observed the changes of TLR2-4 expressions. Western
blot analysis indicated that in naïve or sham operated rats,
TLR2-4 expressions in the thoracic spinal dorsal horn
were very low (Figure 3A, C). After intrapancreatic infu-
sion of TNBS, TLR2 and TLR4 expressions were still very
low, compared with that of naïve or sham group (Figure
3D, F; P > 0.05). Interestingly, TLR3 was significantly
increased in the spinal cord, from 1 w after CP induction
(P < 0.05, Figure 3B, E) and was maintained at a very high
level up to 5 w (P <0 . 0 5 ,vs naive group). We previously
Figure 1 Trinitrobenzene sulfonic acid (TNBS) infusion-induced
rat chronic pancreatitis. (A-D) Hematoxylin and eosin staining of
the pancreas in (A) naïve group, (B) sham operated group, (C)
trinitrobenzene sulfonic acid (TNBS)-1 w group and (D) TNBS-5 w
group. (E) The severity of CP was morphological assessed by
semiquantitative scoring: graded glandular atrophy (0-3);
intralobular, interlobular and periductal fibrosis (0-3); inflammatory
cells infiltrations (0-3). * P < 0.05 compared with that of naïve
group.
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activation after CP induction [11], so TLR3 was assumed
to be expressed on spinal astrocytes and mediated CP-in-
duced astrocytic activation. We thus observed the cellular
localization of TLR3 in the thoracic spinal dorsal horn 5 w
after CP induction. Immunofluorescence double labeling
showed that TLR3 was highly expressed on glial fibrillary
acidic protein (GFAP)-positive astrocytes (Figure 4A-D),
with a very low level on spinal microglia (Figure 4E). No
obvious TLR3 immunoreactivities could be detected on
spinal neurons (Figure 4F).
Figure 2 Chronic pancreatitis-induced rat mechanical
sensitivity of the abdomen. (A) Response frequencies to
mechanical stimulation of the abdomen with the 40.7 mN of von-
Frey filaments before (base) and up to 5 w after pancreatic infusion
with TNBS (TNBS group, n = 6), vehicle (sham group n = 6) or naïve
control (n = 6). (B) Response frequencies to mechanical stimulation
of the abdomen with von-Frey filaments of various strengths at 5 w
in the rats of TNBS (n = 6), sham (n = 6) or naïve (n = 6) groups. *
P < 0.05 compared with that of naïve group.
Figure 3 Chronic pancreatitis-induced significant increase of toll like receptor (TLR) 3 in the thoracic spinal dorsal horn.( A - C )
Representative Western blot data showing the expressions of TLR2-4 in naïve, sham and 1-5 w following TNBS infusion. (D-F) statistical analysis
on Western blot results. * P < 0.05 compared with that of naïve group. In naïve or sham operated rats, TLR 2-4 expressions in the thoracic spinal
dorsal horn were at very low levels. After intrapancreatic infusion of TNBS, TLR 2 and TLR 4 were still at a very low level, compared with that of
naïve and sham group. TLR 3 was significantly increased in the spinal cord, from 1 w after CP induction. TLR 3 was increased gradually and
maintained at a very high level up to 5 w.
Figure 4 Double immunostaining showing the cellular location
of toll like receptor (TLR) 3 with antibodies against astrocytic
specific marker glial fibrillary acidic protein (GFAP, A-D),
microglial marker OX42 (E) and neuronal marker NeuN (F).W e
observed that TLR 3 was highly expressed on spinal astrocytes, and
also expressed on microglia in a very low level. Single arrows: GFAP-
positive and TLR 3-negative cell structures; Single arrowheads:
GFAP-negative and TLR 3-positive cell structures; Double arrows:
double-labeled cell structures. Scale bars = 200 μm in C, applied in
A-C, 50 μm in F, applied in D-F.
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CP-induced mechanical allodynia
In order to testify our hypothesis that TLR3 contributed
to CP-induced neuropathic pain, we used a kind of TLR3
ASO to knockdown the expression of TLR3 and observed
the behavioral consequences as well as cellular and mole-
cular changes. TLR3 ASO could specifically bind to the
TLR3 RNA and reduce spinal TLR3 expression. TLR3
mismatch oligodeoxynucleotide (MO) was selected as a
negative control. Infusion with TLR3 ASO (0.1 nmol/μl,
from 4th w to 5th w following TNBS infusion) signifi-
cantly, even though not completely, attenuated mechani-
cal allodynia (P < 0.05, Figure 5A). However, TLR3 ASO
did not influence RFs of sham operated rats. We further
observed that TNBS-induced allodynia was remarkably
attenuated by TLR3 ASO, in a dose-dependent manner
(Figure 5B). Western blot con f i r m e dt h a ti n t r a t h e c a l
infusion of TLR3 ASO, but not TLR3 MO, significantly
Figure 5 Intrathecal infusion of toll like receptor (TLR) 3 antisense oligodeoxynucleotide (ASO) on mechanical allodynia and astrocytic
activation. TLR 3 ASO or mismatch oligodeoxynucleotide (MO) was intrathecally infused for 1 w after pancreatitis induction. (A) Response
frequencies to mechanical stimulation of the abdomen with von-Frey filaments of various strengths at 5 w in the rats of trinitrobenzene sulfonic
acid (TNBS)-MO, sham-MO, sham-ASO (0.1 nmol/μL) and TNBS-ASO (0.1 nmol/μL) group. *, # P < 0.05 compared with that of sham-MO or TNBS-
MO group, respectively. (B) TNBS-induced allodynia was significantly attenuated by TLR 3 ASO in a dose-dependent manner. * P < 0.05
compared to 0.1 nmol/μL group. (C, D) Representative Western blot data showing the expressions of TLR 3 and glial fibrillary acidic protein
(GFAP) following different treatments. (E, F) statistical analysis on Western blot results. Intrathecal infusion of TLR 3 ASO, but not TLR 3 MO,
significantly blocked CP-induced TLR 3 up-regulation and astrocytic activation. *, # P < 0.05 compared to sham-MO or TNBS-MO group,
respectively.
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These results suggested that TLR3 might contribute to
CP-induced mechanical allodynia.
TLR3 ASO significantly reversed CP-induced astrocytic
activation, as well as cytokines expressions
Since TLR3 was highly expressed on spinal astrocytes
after CP induction, we thus investigated the role of
TLR3 ASO on CP-induced astrocytic activation. CP-
induced astrocytic activation in the thoracic spinal dor-
sal horn was remarkably suppressed by TLR3 ASO (Fig-
ure 5D). GFAP expression in the TNBS-MO group was
significantly higher than that of sham group (P <0 . 0 5 ) .
However, GFAP levels in the TNBS-ASO groups were
much lower than that of the TNBS-MO group, although
still higher than that of the sham groups. We then
further measured the cytokines expression in the rat
thoracic spinal dorsal horn following different treat-
ments. A significant up-regulation of cytokines was
observed after CP-induced chronic pain. In the TNBS-
MO group, we observed significant increases of IL-1b
(261.4% ± 26.6, P <0 . 0 5 ,F i g u r e6 A ) ,T N F - a (235.1% ±
25.3, P < 0.05, Figure 6B), IL-6 (195.7% ± 18.9, P < 0.05,
Figure 6C) and monocyte chemotactic protein-1 (MCP-
1) (315.8% ± 30.3, P < 0.05, Figure 6D) compared with
those of sham groups. Intrathecal infusion of TLR 3
ASO could significantly attenuated CP-induced up-regu-
lation of IL-1b and MCP-1, in a dose dependent man-
ner. However, TNF-a or IL-6 was not significantly
influenced by TLR3 ASO. However, cyclooxygenase-2
(COX-2) in the thoracic spinal dorsal was not increased
in CP conditions, either influenced by intrathecal infu-
sion of TLR3 ASO (Figure 6E).
Discussion
Cumulating evidence supports that the inflammatory
response in the spinal cord plays an important role in
inducing and maintaining pathological pain [20-23]. In
this context, we recently demonstrated that in a rat
model of CP, astrocytic activation could be observed in
the thoracic spinal dorsal horn [11]. In the present
study, we further elucidate the molecular mechanisms
underlying inflammatory process in the CNS in CP
related pain states. We demonstrate that TLR3, but not
TLR2 or TLR4, is increased in the spinal dorsal horn in
a rat model of TNBS-induced CP. We further show that
intrathecal injection of TLR3 ASO could significantly
attenuate CP-induced mechanical allodynia, astrocytic
activation, and cytokines expressions.
TLR2-4 have been implicated in pathological pain
[13,14,16,17]. Previous studies showed a significant up-
regulation of TLR2-4 in nerve injury-induced
Figure 6 Intrathecal infusion of toll like receptor (TLR) 3 antisense oligodeoxynucleotide (ASO) on cytokine/chemokine expressions
revealed by real-time PCR. Changes of (A) IL-1b, (B) TNF-a, (C) IL-6, (D) monocyte chemotactic protein-1 (MCP-1), and (E) cyclooxygenase 2
(COX-2) mRNA levels were determined in the T10 region of the dorsal spinal cord of pancreatic or sham rats. Significant increases of IL-1b, TNF-
a, IL-6 and MCP-1, except COX-2, were observed in spinal cord of pancreatic rats. TLR3 ASO significantly attenuated up-regulation of IL-1b and
MCP-1, but not TNF-a or IL-6. *, # P < 0.05 compared to sham-MO or TNBS-MO group, respectively.
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display significantly attenuated behavioral hypersensitiv-
ity and decreased expression of spinal glial activation
and proinflammatory cytokines [24]. However, we
observed no change of spinal TLR2 or 4 in CP model.
We speculate the most probable reason is the different
cellular localizations of TLR2, 3 and 4. Microglia consti-
tutively express a wide range of TLR2-4 at high levels
[25,26]. In comparison, astrocytes express TLR2 and 4
at lower levels, with particularly high levels of TLR3
[27-29]. This was also confirmed by double immunos-
taining in the present study. We reported that astro-
cytes, but not microglia, were activated in the spinal
cord in CP conditions [11]. Probably, receptors on astro-
cytes, rather than on microglia, play more essential roles
in pain of CP. In nerve injury-induced neuropathic pain
model, astrocytes contribute more to the maintenance
of mechanic allodynia, while microglia contribute more
to the development [30,31]. In our previous study, no
obvious spinal microglial activation in CP conditions
was detected, possibly because of the observing window.
However, we can not exclude the contribution of micro-
glia in the initiation of CP-induced pain. In addition, the
role of TLR2 and 4 in the very early stage (<1 w) of CP-
induced pain remains to be elucidated. However, our
results at least indicate that TLR3 is more important in
the chronic phase of CP-induced pain.
We then further confirm that TLR3 is essential for
astrocytic activation and mechanical allodynia. Antisense
strategies have been widely used to locally knock-down
a specific gene and protein, especially when specific
inhibitors or antagonists are lacking. Previous study has
also confirmed the role of TLR3 in spinal nerve injury
induced pathological pain, with a kind of TLR3 ASO
[16]. However, knock-down of TLR3 attenuates the acti-
vation of spinal microglia, but not astrocytes in the
nerve injury model. We think the most probable reason
for the different results is the difference of the models.
Although somatic and visceral pain share some similari-
ties in the underlying mechanism, there are still lots of
differences [32]. Another explanation is the observing
window. They observed in a very short period following
nerve injury (1 w). Microglial responses typically pre-
cede astrocyte activation [31]. TLR3 activation in micro-
glia might have a role in the early establishment of
n e u r o p a t h i cp a i n .H o w e v e r ,i nt h el a t es t a g e ,a s t r o c y t i c
TLR3 may contribute to the maintenance of neuropathic
pain, as what we observed in the present study.
The coming question is how TLR 3 mediates astrocy-
tic activation in CP conditions. The cytoplasmic portion
of TLRs shows high similarity to that of the IL-1 recep-
tor family, and is called the Toll/IL-1 receptor (TIR)
domain [33]. In the signaling pathway downstream of
the TIR domain, there is a TIR domain-containing
adaptor, MyD88, which recruits IL-1 receptor-associated
kinase (IRAK) to TLRs through interaction of the death
domains of both molecules. Activation of IRAK leads to
the activation of c-Jun N-terminal kinase (JNK) and NF-
B [34]. In neuropathic pain, activation of JNK has been
proved to be exclusively present on spinal astrocytes
and is essential for astrocytic activation and pain proces-
sing [12]. So probably in CP conditions, TLR3 could
induce astrocytic JNK activation and consequent pain
behavior. Traditionally, TLR3 is known to recognize
double-stranded RNA [35] and double-stranded mRNA
[36], following viral infection. In the process of CP,
virus is considered as a critical factor [18]. A recent
study even suggested double-stranded RNA, a ligand of
TLR3 could induce CP [19]. However, in the TNBS-
induced CP model, there is no viral infection. It is
reported that the pro-inflammatory cytokines induced
following CP could mediate TLR3 activation. Cultured
astrocytes from human subcortical samples generally
express TLR3 at very low levels. Upon activation with
different pro-inflammatory cytokines (IL-1b,T N F - a
etc), strong and preferential induction of TLR3 was
observed consistently [37]. We indeed observed IL-1b,
TNF-a and IL-6 were significantly increased in the
spinal cord of pancreatic rats. Spinal IL-1b released fol-
lowing TNBS injection may also activate TLR3 because
of the high similarity between TLR3 and IL-1 receptor.
Pancreatic inflammation results in immune activation
and release of a host of other pro-inflammatory cyto-
kines [38,39], which could have direct influences on
spinal TLR3. Alternatively, such substances may serve as
retrogradely transported signals to influence gene activa-
tion in dorsal root ganglia (DRG) neurons, leading to
synthesis of cytokines and their release in the dorsal
horn termination area of the involved sensory nerves.
Pro-inflammatory cytokines could not only increase
TLR3 expression, but could also be induced by TLR3
activation [40]. Activated astrocytes release varieties of
cytokines/chemokines that enhance neuronal activity
and further stimulate TLR3. In the present study, we
o b s e r v e dt h a tI L - 1 b and MCP-1 were increased follow-
ing CP. Besides, TLR3 ASO could block IL-1b and
MCP-1 expressions. These data suggest that IL-1b and
MCP-1 are probably located on spinal astrocytes and
are induced by TLR3 activation. After activation, astro-
cytes release IL-1b, which activates IL-1 receptor on
neurons and consequently, enhancing neuronal activity
and synaptic transmission [41,42]. Spinal astrocytes also
release the chemokine MCP-1, which could induce pain
behavior and phosphorylation of extracellular signal-
regulated kinase (ERK) in super f i c i a ls p i n a lc o r dd o r s a l
horn neurons [12]. This positive feedback circuit
enlarges the effect of nerve injury on nociception and
makes it more difficult to develop a clinical therapy for
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in cultured human astrocytes, TLR3 triggers enhanced
production of anti-inflammatory cytokines including IL-
9, IL-10, and IL-11, but not inflammatory cytokines
observed in the present study. The possible explanation
for the discrepancy could be different conditions
(in vitro and in vivo) and different origins of astrocytes
(brain and spinal cord).
TNF-a and IL-6 are increased in the spinal cord in CP
conditions. However, TLR3 ASO has no effect on TNF-a
or IL-6 expression. We thus conclude that TNF-a and
IL-6 may not be induced by TLR3 activation, or synthe-
sized in astrocytes. The possible origins of TNF-a and
IL-6 are activated neurons in the spinal dorsal horn
[23,44], or even macrophages. Besides, we did not
observe expression change of spinal COX-2 following CP
induction. However, other studies reported that TLR3
stimulation could induce TNF-a, IL-6 and even COX-2
in vitro [16,37,40]. Although recent studies suggest that
COX-2 plays an essential role in peripheral and central
pain processing [45], spinal COX-2 may not be involved
in CP-induced pain. In addition, in the present study, we
only detected spinal COX-2 expression 5 w after TNBS
infusion. Whether spinal COX-2 is increased in the very
early stages following CP-injection is to be determined.
Conclusions
O u rr e s u l t sp r o v i d ee v i d e n c ef o rt h ei n v o l v e m e n to f
spinal TLR3 in CP-induced chronic pain. And we pre-
sent a probable “TLR3 - astrocytes - IL-1b/MCP-1”
pathway as a positive feedback loop in the spinal dorsal
horn in CP conditions, which could be new targets for
treating severe and persistent pain in CP patients.
Methods
All experimental procedures received approval from the
Animal Use and Care Committee for Research and Educa-
tion of the Fourth Military Medical University (Xi’an, P. R.
China) and also the ethical guidelines to investigate experi-
mental pain in conscious animals. All efforts were made to
minimize the number of animals used and their suffering.
Induction of pancreatitis
Male Sprague-Dawley rats (250 and 300 g) were used in
the study. Animals were given free access to drinking
water and standard food pellets until 12 h prior to induc-
tion of pancreatitis, at which point food was withdrawn.
TNBS-induced rat pancreatitis model was built according
to our previous study [11]. Briefly, the common bile duct
was closed temporarily near the liver with a small vascular
clamp. A blunt 28 gauge needle with PE 10 tubing
attached was inserted into the duodenum and was guided
through the papilla into the duct and was secured with
suture. TNBS solution (0.5 ml, 2%) in 10% ethanol in
phosphate buffered saline (PBS, pH 7.4) was infused into
the pancreatic duct over a period of 2-5 min at a pressure
of 50 mmHg. After 30 min exposure to TNBS, needle and
tubing were removed. The hole in the duodenum was
sutured and the vascular clamp was removed restoring the
bile flow. All the procedures in the sham group were same
as that in the TNBS group, except that the same volume
of saline instead of TNBS was infused into the duct.
Administration of drugs
TLR3 ASO (5’-AACAATTGCTTCAAGTCCTCAAG
TCC-3’)a n dT L R 3M O( 5 ’-ACTTCAACAGTAGAC-
TACTAGACTAC-3’) were synthesized by Sangon Bio-
technology Co. (Shanghai, China). For intrathecal
infusion, laminectomy was performed at the level of the
thoracic vertebrae, under pentobarbital anesthesia
(45 mg kg
-1, i.p.). A polyethylene (PE10) catheter (I.D.
0.28 mm and O.D. 0.61 mm) was passed caudally from
the T9 to the T12 level of the spinal cord, and 2 cm of
t h ef r e ee n d i n gw a sl e f te x p o s e di nt h eu p p e rt h o r a c i c
region. Rats were allowed to recover for a period of 3 - 5
days before further use. Only the animals judged as neu-
rologically normal and that showed complete paralysis of
the tail and bilateral hind legs after administration of 2%
lidocaine (10 μL) through the intrathecal catheter were
used for the following experiments. The catheter was
connected to an osmotic pump (7-day pump, 1 μl/h;
Durect, Cupertino, CA, USA) was filled with ASO (0.01,
0.1 or 1 nmol/μL) or MO (1 nmol/lL) in normal saline.
All the rats were divided in t ot h r e eg r o u p s :T N B S
group (n = 54), sham group (n = 42), and naïve controls
(n = 6). In order to study the time course of TLRs
change, we sacrificed every 6 rats in TNBS group at 1,
2 ,3 ,4a n d5wa f t e rT N B Si n f u s i o n .A t4wa f t e rs u r -
gery, other rats in TNBS (n = 24) and sham group (n =
24) were each further divided for drug injection: TNBS-
ASO (or sham-ASO) group: TLR 3 ASO was intrathe-
cally infused on pancreatitic (0.01, 0.1 or 1 nmol/μL, n
=6e a c h )o rs h a mo p e r a t e dr a t s( n=6 ,1n m o l / μL
only); TNBS-MO (or sham-MO) group: TLR3 MO was
injected on pancreatitic (n = 6) or sham operated rats (n
= 6). At 5 w after surgery, all the rats including naïve
rats (n = 6) and sham rats without intrathecal injection
(n = 6) were sacrificed for further experiments.
Pain behavioral test
Mechanical allodynia was measured with von Frey fila-
ments (Stoelting, Kiel, WI, USA). Testing was performed
according to our protocol reported previously [11]. Prior
to test, the belly skin of the rat was shaved and area
designated for stimulation was marked. Rats were placed
in a plastic cage with a mesh floor and were given 30
min for adaptation before testing. The von Frey fila-
ments were applied from underneath through the mesh
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ent points on the surface. A single trial consisted of 10
applications each for 1-2 s with a 15 s interval between
applications allow the animal to cease any response and
return to a relatively inactive position. A positive
response consisted of the rat raising its belly (withdrawal
response). The data were expressed as a percentage of
the positive responses with each filament for each rat.
In the time-course study, behavioral tests were per-
formed before and once weekly for up to 5 w after
induction of pancreatitis with a single force of von Frey
filament (40.7 mN). In the strength-response study, rats
were tested 5 w after pancreatitis induction with a series
of von Frey filaments (2.29, 2.75, 6.76, 16.6, 40.7, 69.2
and 120 mN).
Pancreatic histology
Rats were deeply anesthetized with sodium pentobarbital
(60 mg/kg, i.p.) and the pancreas was obtained and then
fixed in 4% paraformaldehyde in phosphate buffered
(PB, pH 7.4) at 4°C overnight. Pancreatic tissue was
then transferred to progressive xylene washes and was
placed in cassettes and embedded in paraffin. Paraffin
blocks were cut in 5-μms e c t i o n sa n ds t a i n e dw i t h
hematoxylin and eosin. Histological sections were ana-
lyzed by a pathologist in a double blinded manner. The
severity of CP was morphologically assessed by semi-
quantitative scores according to previous reports: graded
glandular atrophy (0-3); intralobular, interlobular and
periductal fibrosis (0-3); inflammatory cells infiltrations
(0-3) [46,47].
Western blot
All animals were rapidly sacrificed and the thoracic (T) 10
spinal cord was rapidly harvested and then was frozen on
the dry ice. Then the spinal dorsal horn was quickly
micro-dissected. Spinal cord was then homogenized with a
hand-held pestle in SDS sample buffer (10 ml/mg tissue),
which contained a cocktail of proteinase inhibitors. After
protein concentration was measured, proteins (50 μg)
were heated for at 100°C for 5 min and loaded onto 10%
SDS-polyacrylamide gels with standard Laemmli solutions
(Bio-Rad Laboratories, CA, USA). The proteins were elec-
troblotted onto a polyvinylidene difluoride membrane
(PVDF, Immobilon-P, Millipore, Billerica, MA, USA). The
membranes were placed in a blocking solution containing
Tris-buffered saline with 0.02% Tween (TBS-T) and 5%
non-fat dry milk, for 1 h, and incubated overnight under
gentle agitation with primary antibodies: rabbit anti-TLR2
(1: 100; Santa-Cruz Biotechnology, Santa Cruz, California,
USA), rabbit anti-TLR3 (1: 100; Santa-Cruz Biotechnol-
ogy), rabbit anti-TLR4 (1: 100; Santa-Cruz Biotechnology)
and rabbit anti-b-actin (1: 1000; Sigma, St. Louis, MO,
USA). Bound primary antibodies were detected with the
anti-rabbit horseradish peroxidase (HRP)-conjugated sec-
ondary antibody (1:10,000; Amersham Pharmacia Biotech
Inc., Piscataway, NJ, USA). Between each step, the immu-
noblots were rinsed with TBS-T. All reactions were
detected by the enhanced chemiluminescence (ECL)
detection method (Amersham). The densities of protein
blots were analyzed by using Labworks Software (Ultra-
Violet Products, UK). The densities of target proteins and
b-actin immunoreactive bands were quantified with back-
g r o u n ds u b t r a c t i o n .T h es a m es i z eo fs q u a r ew a sd r a w n
around each band to measure the density and the back-
ground near that band was subtracted. Target protein
levels were normalized against b-actin levels and expressed
as relative fold changes compared to the naïve control or
to the sham-MO group.
Real-time RT-PCR
Rats were deeply anesthetized with sodium pentobarbital
(60 mg/kg, i.p.), the animals were rapidly sacrificed and
the thoracic (T) 10 spinal cord was rapidly harvested
and then was frozen on the dry ice. Then the spinal
dorsal horn was quickly micro-dissected. RNA was
Table 1 Primers sequence for the rat genes characterized in this experiment
Genes Primers Accession number
MCP-1 Forward primer 5’-CAGATCTCTCTTCCTCCACCACTAT-3’ M57441
Reverse primer 5’-CAGGCAGCAACTGTGAACAAC-3’
IL-1b Forward primer 5’-TGCTGATGTACCAGTTGGGG-3’ NM031512
Reverse primer 5’-CTCCATGAGCTTTGTACAAG-3’
IL-6 Forward primer 5’-GCCCTTCAGGAACAGCTATG-3’ NM012589
Reverse primer 5’-CAGAATTGCCATTGCACAAC-3
TNF-a Forward primer 5’-TGATCGGTCCCAACAAGG A-3’ AY427675
Reverse primer 5’-TGCTTG GTG GTTTGCTACGA-3’
COX-2 Forward primer 5’-CAGTATCAGAACCGCATTGCC-3’ U03389
Reverse primer 5’-GAGCAAGTCCGTGTTCAAGGA-3’
GAPDH Forward primer 5’-CCCCCAATGTATCCGTTGTG-3’ NM01008
Reverse primer 5’-TAGCCCAGGATGCCCTTTAGT-3’
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(cDNA) was synthesized with oligo (dT)12-18 using
Superscript™ III Reverse Transcriptase for RT-PCR
(Invitrogen, Carlsbad, CA, USA). The primers used in
t h ep r e s e n ts t u d yw e r ep r e s e n t e di nT a b l e1 .E q u a l
amounts of RNA (1 μg) were used to prepare cDNA
using the SYBR
® Premix Ex Taq™ (Takara, Tokyo,
Japan) and analyzed by real-time PCR in a detection sys-
tem (Applied Biosystems, Foster City, CA, USA). The
amplification protocol was: 3 min at 95°C, followed by
45 cycles of 10 s at 95°C for denaturation and 45 s at
60°C for annealing and extension. All experiments were
repeated twice and, in each experiment, PCR reactions
were done in triplicate. Target cDNA quantities were
estimated from the threshold amplification cycle num-
ber (Ct) using Sequence Detection System software
(Applied Biosystems). GAPDH was served as an endo-
genous internal standard control for variations in RT-
PCR efficiency.
Immunofluorescent double labeling
At 5 w after TNBS infusion, rats were perfused through
the ascending aorta with 100 ml of normal saline fol-
lowed by 500 ml of 0.1 M phosphate buffer (PB, pH 7.3)
containing 4% paraformaldehyde and 2% picric acid,
under deep anesthesia with sodium pentobarbital (60
mg/kg, i.p.). After the perfusion, the spinal segments
T10 was removed and postfixed in the same fixative for
2-4 h and then cryoprotected for 24 h at 4°C in 0.1 M
PB containing 30% sucrose.
Transverse spinal sections (30 μm thickness) were cut
in a cryostat, collected in 0.01 M phosphate-buffered
saline (PBS, pH 7.3) and were then processed for immu-
nofluorescent staining. Sections were rinsed in 0.01 M
PBS (pH 7.3) for three times (10 min each), and then
blocked with 2% goat serum in 0.01 M PBS containing
0.3% Triton X-100 for 1 h at the room temperature
( R T )a n dt h e nu s e df o ri m m u n o f l u o r e s c e n ts t a i n i n g .
The sections were incubated overnight at 4°C with the
primary antibodies: rabbit anti-TLR 3 (1: 100; Santa-
Cruz Biotechnology) mixed with mouse anti- GFAP
(1: 5000; Millipore, Temecula, CA, USA) or mouse anti-
neuronal-specific nuclear protein (NeuN, 1:5000; Milli-
pore) or mouse anti-OX-42 (1: 1000; Millipore). The
sections were then washed for three times in 0.01 M
PBS (10 min each) and then incubated for 2 h at RT
with the corresponding secondary antibody: FITC-conju-
gated horse anti-mouse IgG (1:200; Vector, Burlingame,
CA, USA) and Alexa 594-conjugated donkey anti-rabbit
IgG (1:800; Molecular Probes, Rockford, IL, USA).
Images were obtained using a confocal laser microscope
(FV1000; Olympus, Tokyo, Japan) and digital images
were captured with Fluoview 1000 (Olympus). Twelve
nonadjacent sections were selected randomly from all
the sections for the scanning. The z-separation was 4.6
μm under 20 × objective magnifications and was 1.0 μm
under 60 × objective magnifications.
Data analysis
All data were collected by experimenters blind to the
surgery and treatments and statistical analysis was done
by using SPSS software (version 12.0). Data were
expressed as means ± standard error mean (means ± S.
E.M.). Repeated measures ANOVA (with Bonferroni
confidence interval adjustment) was used and conducted
for data of pancreatic pathology. Two-way analysis of
variance (ANOVA) (Group × Day) was used for analysis
of behavioral data as well as Western blot and real-time
PCR analysis. Dunnett’sCpost hoc test, assuming the
variances were not equal, was employed whenever
appropriate and significance was set at 0.05 for all statis-
tical tests.
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